Henry Ford Health

Henry Ford Health Scholarly Commons
Cardiology Articles

Cardiology/Cardiovascular Research

1-1-2015

Embolic Stroke as the Initial Manifestation of Systemic Lupus
Erythematosus
Reshma M. Khan
Rajaie Namas
Sachin Parikh
Henry Ford Health, SPARIKH2@hfhs.org

Bernard Rubin

Follow this and additional works at: https://scholarlycommons.henryford.com/cardiology_articles

Recommended Citation
Khan RM, Namas R, Parikh S, Rubin B. Embolic stroke as the initial manifestation of systemic lupus
erythematosus. Case Rep Rheumatol. 2015;2015:373201.

This Article is brought to you for free and open access by the Cardiology/Cardiovascular Research at Henry Ford
Health Scholarly Commons. It has been accepted for inclusion in Cardiology Articles by an authorized
administrator of Henry Ford Health Scholarly Commons.

Hindawi Publishing Corporation
Case Reports in Rheumatology
Volume 2015, Article ID 373201, 5 pages
http://dx.doi.org/10.1155/2015/373201

Case Report
Embolic Stroke as the Initial Manifestation of
Systemic Lupus Erythematosus
Reshma M. Khan,1 Rajaie Namas,2 Sachin Parikh,3 and Bernard Rubin1
1

Department of Internal Medicine, Division of Rheumatology, Henry Ford Hospital, Wayne State University, Detroit, MI 48202, USA
Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI 48109, USA
3
Department of Internal Medicine, Division of Cardiology, Henry Ford Hospital, Detroit, MI 48202, USA
2

Correspondence should be addressed to Reshma M. Khan; reshmamkhan@gmail.com
Received 26 May 2015; Accepted 9 July 2015
Academic Editor: Masataka Kuwana
Copyright © 2015 Reshma M. Khan et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
We present a case of a 21-year-old African-American female with no significant medical history, who presented to the emergency
department with a one-week history of blurry and double vision. Ophthalmology evaluation revealed bilateral retinal artery
occlusion. Further workup with imaging of the brain was consistent with an ischemic stroke. Hereditary hypercoagulable workup
was unremarkable and initial testing for antiphospholipid syndrome was positive. She underwent transesophageal echocardiogram
(TEE), which showed severe mitral regurgitation and thickening of mitral valve leaflets consistent with Libman-Sacks endocarditis.
Autoimmune workup was positive for IF-ANA, anti-RNP, and anti-Smith antibody. She fulfilled 4/11 of the ACR criteria and met
5 of the SLICC (Systemic Lupus International Collaborating Clinics) criteria for lupus (nonscaring alopecia, thrombocytopenia,
positive ANA, and positive anti-Smith and positive anti-phospholipid antibodies). This case highlights the importance of early
recognition of underlying connective tissue diseases and timely management of these diseases in young patients with no previous
manifestations of diseases.

1. Case Report
A previously healthy 21-year-old African-American female
was transferred to our hospital for escalation of treatment.
She presented to the emergency department one week prior
to this admission with progressive worsening of the vision in
the right eye described as double vision associated with pain
and redness. Approximately over the last three weeks prior to
this admission she was experiencing excruciating headaches
associated with her eye symptoms. She was evaluated at her
primary-care physician’s office and was found to have an
elevated blood pressure and a new heart murmur. Review
of systems was positive for unintentional weight gain of
13.5 kilograms in the last eight months, excessive fatigue,
fever, difficulty focusing, one episode of painful oral ulcer
on the roof of her mouth, change in the hair texture with
nonscarring alopecia, shortness of breath with exertion, and
constipation. She reports no history of malar rash, photosensitivity, arthralgia, morning stiffness, thromboembolic

diseases, or miscarriages. Her family history was significant
for systemic lupus in her mother’s cousin. She was smoking
0.25 PPD, consumed alcohol socially, and denied any illicit
drug abuse. She was sexually active with men and used
condom for contraception. Her home medications included
as needed Motrin and tramadol.
On physical exam, she was awake, lethargic, and afebrile
with a pulse of 90 beats per minute, blood pressure of
180/95 millimeters of mercury, and a BMI of 26.58 kg/m2 .
Ophthalmic exam revealed a right eye lid ptosis, down and
out position, and mydriasis, consistent with third nerve palsy.
Her visual field exam revealed a right visual field defect with
total superior temporal, inferior temporal, superior nasal, and
inferior nasal deficiencies and left visual field defect with
total inferior temporal and inferior nasal deficiencies. Cardiovascular exam was positive for III/VI holosystolic murmur
at the apex and significant pitting edema in her both lower
extremities. Her musculoskeletal exam was unremarkable.
Skin exam showed a diffuse macular hyper pigmentation of
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Table 1: Time course of laboratory data on initial presentation to ER, on presentation to our institution, and on discharge.

Laboratory
Sodium
Potassium
Chloride
Carbon dioxide
Blood urea nitrogen
Serum creatinine
White blood cell
Hemoglobin
Platelet count
Absolute neutrophil count
Absolute lymphocyte count
Sedimentation rate

Reference range
135–145 mmol/L
3.5–5.0 mmol/L
98–111 mmol/L
21–35 mmol/L
10–15 mg/dL
<1.03 mg/dL
3.8–10.6 K/𝜇L
12.0–15.0 gm/dL
150–450 K/𝜇L
1.80–7.70 K/𝜇L
1.10–4.00 K/𝜇L
0–20 mm/hr

Initial presentation to ER
135
3.9
100
26
23
1.1
9.3
11.4
71
NA
NA
41

Presentation at our institute
135
4.7
104
26
30
1.56
8.4
11.3
115
4.54
2.94
79

At the time of discharge
140
4.4
108
21
23
1.02
13.1
9.4
207
NA
NA
30

NA: not available.

her back and a small-healed blister over the right shoulder.
Her performance on a brief cognitive screen was remarkable for difficulties with basic attention, motor sequencing,
impulse control, and retrieval of information (Cog Log Score
11/30).
The brain CT scan findings in the emergency department
were consistent with an acute to subacute infarct in the
posteroparietal/occipital lobe region, and the follow-up MRI
showed scattered areas of restricted diffusion, suggestive of
infarcts in the bilateral cerebral and cerebellar hemispheres
from a likely embolic source, and focal chronic encephalomalacia changes were seen involving the right temporal-occipital
lobe. MRA and MRV of brain and neck were unremarkable
with no significant stenosis. Ophthalmology evaluation was
positive for bilateral central retinal artery occlusion and
vitreal hemorrhage (Figure 1). She underwent a TEE that
showed moderate to severe mitral regurgitation with mild
mitral valve thickening, mitral valve leaflets not coapting,
and a small mass on the atrial side of the anterior mitral
valve leaflet possibly representing old vegetation (Figure 2).
The concern was raised for possible Libman-Sacks endocarditis versus infective endocarditis. Hereditary coagulopathy
workup and infectious workups including three series of
blood cultures, hepatitis panel, HIV screen, and Fluorescent Treponemal Antibody Absorption Test (FTA-ABS) were
negative. Workup for antiphospholipid syndrome revealed
positive lupus anticoagulant panel (high prothrombin time,
high PTT, and high DRVVT), low titer cardiolipin IgG 23.7
(<15: absent, 15–19: inconclusive, 20–79: moderate positive,
and ≥80: high positive), and negative beta 2 glycoprotein.
The autoimmune workup was remarkable for elevated
inflammatory markers, positive IF-ANA 1 : 640 (homogenous
pattern), positive RNP antibody 37 (ref. <20), and positive
Smith antibody 34 (ref. <20). She had normal complements,
negative DNA antibody screen, and negative SSA and SSB
antibodies. Her urine drug screen and pregnancy tests were
negative. Analysis of her urine showed +2 proteins and +3
bacteria; however, no red blood cells or casts were present.
Her initial EKG showed normal sinus rhythm, normal axis,

Figure 1: A fundoscopic exam of the right eye revealing vitreal
hemorrhage and central retinal artery occlusion.

normal intervals, and no ST/T wave changes; chest Xray showed cardiac enlargement with no acute pulmonary
process, and ultrasound of her kidney showed unremarkable
evaluation of the kidneys.
The patient laboratory result at the initial presentation,
at presentation to our hospital, and on discharge is shown in
Table 1.
In view of the unremarkable extensive infectious workup,
hereditary coagulopathy workup, and clinical presentation
accompanied by a positive lupus anticoagulant and lupus
serology, coupled with TEE images, she was diagnosed with
Libman-Sacks endocarditis attributed to aPS and SLE. She
was started on intravenous heparin, which was bridged with
oral warfarin to achieve an INR goal of 2-3. She was also
started on 20 mg of oral prednisone daily in view of her
symptoms related to her diagnosis of SLE. Her condition
was stable throughout her hospital course except for elevated
blood pressure. She did not require renal biopsy as her
urine analysis did not show any dysmorphic red blood cells
or cast, and her renal function gradually normalized. Her
vision failed to improve significantly even after repeated laser
photocoagulation treatment performed by ophthalmology
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(a)

(b)

Figure 2: ((a) and (b)) A cardiac transesophageal echocardiogram revealing severe mitral regurgitation and thickening of mitral valve leaflets
with mitral valve leaflets not coapting and a small mass on the atrial side of the anterior mitral valve leaflet (arrow) suggesting Libman-Sacks
endocarditis.

team. She was discharged home on aspirin 81 mg and warfarin
with INR goal 2-3 and 20 mg of oral prednisone daily.
She eventually underwent mitral valve repair. Mitral valve
biopsy revealed a cardiac valve with a collagenized fibrous
nodule. It was planned to start her on hydroxychloroquine
during her follow-up in the rheumatology clinic. However,
ophthalmology team had concerns for hydroxychloroquine
due to her retinal damage. She was started on mycophenolate
mofetil as a steroid sparring agent. Currently, her clinical
condition has been stable with mycophenolate mofetil, and
she could taper prednisone to 5 mg daily without any relapse.
Her diagnosis of aPS was confirmed by repeating antiphospholipid antibodies on follow-up visit 16 weeks apart.

2. Discussion
SLE is a complex multisystem autoimmune disease which is
diagnosed on the clinical basis supported by an autoimmune
laboratory profile. In 1997, revised criterion to guide the
diagnosis of SLE was established by the American College of Rheumatology (ACR) [1] that requires a serial or
simultaneous presentation of four or more of the listed
symptoms for the diagnosis of lupus, namely, malar rash,
discoid rash, photosensitivity, oral ulcers, arthritis, serositis,
renal disorder, neurologic disorder, hematologic disorder,
immunologic disorder, and antinuclear antibody. Though the
present case did not fulfill the ACR criteria at presentation,
clinical diagnosis of SLE was advocated in the presence of
mitral valve vegetation in an otherwise healthy lady with nonscaring alopecia, thrombocytopenia, and positive IF-ANA,
anti-Smith, and anti-phospholipid antibodies. Interestingly
anti-dsDNA level was within normal range in our patient.
However this has been shown to be highly specific for SLE
but is only present in 70% of cases.
In 1924, Libman and Sacks described valvular lesions in
four patients with lupus and added nonrheumatic verrucous

endocarditis to the syndrome complex of SLE [2]. LibmanSacks valvular lesions are sterile fibrofibrinous vegetations
that favor the left-sided heart valves and usually form on
the ventricular surface of the mitral valve [3]. The disease
progresses from a variable extent of inflammation along with
fibrin deposits acutely to end stage or healed forms with
a fibrous plaque. The pathogenesis is thought to involve
the formation of fibrin-platelet thrombi, which organizes
and leads to fibrosis and scarring with subsequent valve
dysfunction [4]. Data comparing echocardiograph findings
of 342 consecutive patients with SLE demonstrated that
11% of these patients had Libman-Sacks vegetations [5].
Those patients with LSE were likely to have had SLE longer
with higher disease activity and more frequent episodes of
pericarditis, lupus nephritis, and hemolytic anemia. Diverse
and unusual initial presentation in lupus patients diagnosed
with LSE has been reported in the literature [6], including an
interesting case of cardiac arrest in a young lady as an initial
manifestation of LSE [7]. This clinical scenario is unique as it
is the first case to our knowledge reported in rheumatology
literature in an adult patient in whom SLE was manifested
initially as an embolic stroke secondary to LSE.
The modified Duke criteria utilizing pathologic and
clinical criteria can be useful in helping differentiate between
true infective endocarditis and LSE. Our patient only met
one major criterion based on the echocardiograph findings.
In addition infective endocarditis lesions are more likely to
be located at the leaflet’s line of closure, are homogeneous in
echo reflectance, and may show a vibratory or rotary motion.
In contrast, Libman-Sacks vegetations are usually located
at the base, middle, or tip of leaflets, located on the atrial
side of the mitral valve or vessel side of the aortic valve,
and are of variable sizes and shapes and heterogeneous in
echogenicity. The prevalence of Libman-Sacks vegetations is
<10% by transthoracic echocardiogram and up to 30% by
TEE. A recent case reported highlights the role of MRI in
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early recognition of LSE and differentiates between LSE and
infective endocarditis [8].
On presentation, in our patient, there was a thought that
this is a presentation of APS/CAPS given the positive lupus
anticoagulant. When we applied revised Sapporo criteria, she
did not meet criteria for definite APS, as only single reading
of positive test was available to us at the time of presentation
with vascular thrombosis. However, ongoing and cautious
clinical and laboratory reassessment is required in individuals
who do not meet diagnostic criteria for APS, particularly
in patients with other “noncriteria” clinical or laboratory
manifestations associated with but not specific for APS.
Noncriteria clinical findings associated with aPL include
heart valve disease, livedo reticularis, thrombocytopenia,
nephropathy, and neurological manifestations. Noncriteria
laboratory findings associated with APS include IgG or
IgM aCL or anti-beta2-GPI levels in the range of 20 to
39 GPL or MPL units, IgA aCL and IgA anti-beta2-GPI, antiphosphatidylserine and anti-phosphatidylethanolamine antibodies, anti-prothrombin antibodies, and antibodies to the
phosphatidylserine-prothrombin complex. Our patient met
noncriteria clinical findings for APS, including heart valve
disease, thrombocytopenia, neurological manifestations, and
borderline Cardiolipin IgG in addition to single reading of
positive lupus anticoagulant.
Risks of valvular nodules, regurgitation, and verrucous
endocarditis are more prevalent among patients with significantly elevated levels of anti-phospholipid antibodies (aPL).
Many reports support an association. A meta-analysis of 23
primary studies, including 1656 SLE patients (668 with and
988 without aPL) and 508 cases of heart valvular disease,
found a greater than threefold significantly elevated risk of
valvular disease and 3.5-fold elevated risk of Libman-Sacks
endocarditis among those with aPL, compared with those
without aPL. The risk of valvular disease was the highest for
lupus anticoagulant and IgG anticardiolipin antibodies [9].
The literature does not support the clear role of administration of glucocorticoid and/or cytotoxic therapy for valvular lesions, although there have been no trials. Antiplatelet
or anticoagulation therapy should be considered for all
patients with vegetation or significant valvular thickening
and certainly for all patients with thromboembolic events.
Our patient was started on anticoagulation due to her positive
aPS antibody and embolic stroke. The suggested approach
is similar to that in patients without valvular disease in
the antiphospholipid syndrome. Whether anticoagulation
should be recommended for patients with aPL-associated
vegetation who have never had any thromboembolic event
has not been well studied.
Surgical approach with valve replacement or valve repair
may be necessary for some patients who develop severe
mitral or aortic valve regurgitation or rarely for those with
symptomatic stenotic lesions. Our patient underwent mitral
valve repair due to severe mitral valve regurgitation.

was diagnosed with SLE, which was attributed to the following findings: thrombocytopenia, significant elevation of
inflammatory markers, positive lupus serologies, and lupus
anticoagulant antibodies. Brain imaging was consistent with
an embolic stroke. Further workup, including echocardiography, supported the diagnosis of Libman-Sacks endocarditis
in a patient with SLE. This case highlights the importance
of early recognition of underlying connective tissue diseases
with unusual initial presentation and timely management of
these diseases in young patients.

3. Conclusion

[7] T. Tanawuttiwat, M. Dia, T. Hanif, and M. Mihailescu, “Doublevalve libman-sacks endocarditis causing ventricular fibrillation
cardiac arrest,” Texas Heart Institute Journal, vol. 38, no. 3, pp.
295–297, 2011.

In summary, this previously healthy young lady presented
with acute vision changes and stroke like symptoms and
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LSE: Libman-Sacks endocarditis
SLE: Systemic lupus erythematous
aPS: Antiphospholipid syndrome.
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